Literature DB >> 10673693

Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation.

E Holler1, M G Roncarolo, R Hintermeier-Knabe, G Eissner, B Ertl, U Schulz, H Knabe, H J Kolb, R Andreesen, W Wilmanns.   

Abstract

IL-10 is a potent immunosuppressant which inhibits allo-antigen-specific T cell responses. In addition, IL-10 is a strong endogenous anti-inflammatory cytokine. To investigate the role of IL-10 in the induction of acute GVHD following allogeneic bone marrow transplantation (BMT) we performed a prospective study on spontaneous IL-10 production by peripheral blood mononuclear cells (PBMNC) in 84 patients admitted for allogeneic BMT. High spontaneous IL-10 production by PBMNC at the time of admission and prior to any preparative treatment correlated with a subsequent low incidence of GVHD and transplant-related mortality (8%), as compared to patients with low or intermediate IL-10 production (50%, P < 0. 01). Our data demonstrate the prognostic significance of increased IL-10 production in BMT patients and suggest a major role of IL-10 in maintaining immunobalance in the setting of allogeneic BMT. Bone Marrow Transplantation (2000) 25, 237-241.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673693     DOI: 10.1038/sj.bmt.1702126

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  22 in total

1.  The evolving role of statins in hematopoietic stem and progenitor cell transplantation.

Authors:  Mehdi Hamadani; Michael D Craig; Laura F Gibson; Scot C Remick
Journal:  Am J Blood Res       Date:  2011-06-01

Review 2.  Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.

Authors:  S M Cabrera; M R Rigby; R G Mirmira
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

3.  Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.

Authors:  Nils Schoof; Jeremy Franklin; Robert Fürst; Thomas Zander; Frederike von Bonin; Frederic Peyrade; Lorenz Trümper; Volker Diehl; Andreas Engert; Dieter Kube; Daniel Re
Journal:  Oncologist       Date:  2013-01-08

Review 4.  Pathogenesis and management of graft-versus-host disease.

Authors:  Sung W Choi; John E Levine; James L M Ferrara
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

5.  Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience.

Authors:  Evgenios Goussetis; Ioanna Varela; Ioulia Peristeri; Vasiliki Kitra; Kleopatra Spanou; Olga Moraloglou; Anna Paisiou; Sofia Karatasaki; Alexandra Soldatou; Nikki Constantinidou; Stelios Graphakos
Journal:  Cell Mol Immunol       Date:  2011-02-28       Impact factor: 11.530

6.  Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.

Authors:  Ming-Tseh Lin; Barry Storer; Paul J Martin; Li-Hui Tseng; Bryan Grogan; Pei-Jer Chen; Lue P Zhao; John A Hansen
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

7.  IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.

Authors:  Li-Hui Tseng; Barry Storer; Effie Petersdorf; Ming-Tseh Lin; Jason W Chien; Bryan M Grogan; Mari Malkki; Pei-Jer Chen; Lue P Zhao; Paul J Martin; John A Hansen
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

8.  Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.

Authors:  Giorgia Serafini; Marco Andreani; Manuela Testi; MariaRosa Battarra; Andrea Bontadini; Eika Biral; Katharina Fleischhauer; Sarah Marktel; Guido Lucarelli; Maria Grazia Roncarolo; Rosa Bacchetta
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

Authors:  Robert Zeiser; Sawsan Youssef; Jeanette Baker; Neeraja Kambham; Lawrence Steinman; Robert S Negrin
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

10.  Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant.

Authors:  Nicola Gagliani; Tatiana Jofra; Angela Stabilini; Andrea Valle; Mark Atkinson; Maria-Grazia Roncarolo; Manuela Battaglia
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.